“It is game-changing technology, and we’re excited to bring that to market” – Awais Bajwa
In this episode of Data Chats, Chris Richardson interviews Awais Bajwa founder and CEO of Ophthalytics, an applied artificial intelligence company specializing in Artificial Intelligence-based medical diagnostics.
His company is using AI to help detect diabetic retinopathy, which affects millions of people globally. And nearly 1 million people will experience blindness because of the disease each year. More importantly, there aren’t enough retina specialists who can diagnose patients and establish a treatment plan for them.
Using AI, his company is helping primary care physicians and diabetic centers detect the disease.
They discuss:
- Where Awais sources the data for his company and ensures its accuracy
- How he finds valuable feedback that informs its development
- Ways to approach the architectural side of data
Continued Learning
Data Science for Business Leaders
This course teaches you how to partner with data professionals to uncover business value, make informed decisions and solve problems. Learn More
Business-Driven Data Analysis
This course teaches a proven, repeatable approach that you can leverage across data projects and toolsets to deliver timely data analysis with actionable insights. Learn More
